Universal reference book for medicines
Product name: CYCLODYNON ® (CYCLODYNON ® )

Active substance: Agnus castus

Type: Phytomedication used for menstrual disorders, mastodinia and premenstrual syndrome

Manufacturer: BIONORICA (Germany)
Composition, form of production and packaging
Drops for ingestion
in the form of a transparent, yellow-brown liquid with the odor of the fruit of common rod;
there may be a slight deposit during storage.
100 g

dry extract of the fetus ordinary (Agnus castus) 0.192-0.288 g,

which corresponds to 2.4 g of medicinal plant material

Excipients: povidone, sorbitol 70% (non-crystallisable), polysorbate 20, sodium saccharate dihydrate, peppermint flavor, ethanol 96%, purified water.

50 ml - bottles of dark glass with a dropper (1) - packs of cardboard.

100 ml - bottles of dark glass with a dropper (1) - packs of cardboard.


Description of the drug approved by the manufacturer for the printed edition of 2016.


Means of plant origin.
The components of the drug have a normalizing effect on the concentration of sex hormones.
The main active component of the drug is ordinary prutnyak.
Dopaminergic effects of the drug, causing a decrease in prolactin production, eliminate hyperprolactinemia. Increased concentration of prolactin disrupts the secretion of gonadotropins, resulting in disturbances in the maturation of follicles, ovulation and the formation of a yellow body, which subsequently leads to an imbalance between estradiol and progesterone and can cause menstrual irregularities and mastodinia.Unlike estrogens and other hormones, prolactin also has a direct stimulating effect on proliferative processes in the mammary glands, enhancing the formation of connective tissue and causing the expansion of the milk ducts. Reducing the prolactin content leads to the reverse development of pathological processes in the mammary glands and stops the pain syndrome.
Rhythmic development and normalization of the ratio of gonadotropic hormones leads to the normalization of the second phase of the menstrual cycle.


- disorders of the menstrual cycle;

- premenstrual syndrome;

- Mastodynia.


The drug is taken orally 40 drops once a day, in the morning, with a little water.
Drops for oral administration before use should be shaken.
Treatment is carried out for 3 months, without interruption during menstruation.
After the disappearance of symptoms and improvement of the condition should continue treatment for several weeks.
If after the withdrawal of the drug complaints appear again, you need to consult a doctor.


Rarely: allergic skin reactions.

There are data on rare cases of transient psychomotor agitation, confusion and hallucinations.


- individual hypersensitivity to the components of the drug.


The drug should not be used during pregnancy, as well as during breastfeeding.


In case of occurrence at reception of a preparation pains in mammary glands and-or delicacy, depression, and also in case of menstrual disturbances it is recommended to consult with the doctor.

Drops for oral administration should not be used after successful antialcohol treatment.

Patients with diabetes can take Cyclodinone ® drops,
a single dose of the drug contains less than 0.03 counted bread units.
When storing drops for oral administration, a slight precipitation may occur, which does not affect the effectiveness of the preparation.

Impact on the ability to drive vehicles and manage mechanisms

The drug does not affect the ability to drive and control machinery.


Cases of overdose are unknown.


Patients taking antagonists of dopamine receptors may be mutually weakened by drugs.

Interaction with other drugs has not been known to date.


The drug is released by prescription.


The drug should be stored in a place protected from light, inaccessible to children, at a temperature of no higher than 25 ° C.
Shelf life - 3 years. Do not apply the drug after the period indicated on the package.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!